Wright Medical Group (WMGI) Tops Q4 EPS by 6c, Revenues Beat; Offers FY19 Revenue Guidance

Go back to Wright Medical Group (WMGI) Tops Q4 EPS by 6c, Revenues Beat; Offers FY19 Revenue Guidance

Wright Medical Group N.V. Reports 2018 Fourth Quarter and Full-Year Financial Results and Provides 2019 Annual Guidance

February 26, 2019 4:05 PM EST

Fourth Quarter 2018 Net Sales, Including Cartiva, of $238 Million; Full-Year 2018 Net Sales, Including Cartiva, of $836 Million

Cartiva Revenue of $9.5 Million From October 10, 2018 Closing Date Through Year-End

Fourth Quarter 2018 Net Loss From Continuing Operations of $23 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $44 Million

Full-Year 2018 Net Loss From Continuing Operations of $169 Million; Non-GAAP Adjusted EBITDA From Continuing Operations of $117 Million

Company Provides Full-Year 2019 Net Sales Guidance of $954 Million to $966 Million

 Company... More